Genetic testing of papillary thyroid tumor samples
Part of Cancer, Hormones & metabolism clinical trials.
This trial studies the genetic “mutations” in papillary thyroid cancer tumors using tumor tissue. The goal is to better describe tumor genetic patterns, which may help researchers understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with papillary thyroid cancer
- Your study team can get your tumor tissue for genetic testing
- You are willing and able to give consent to join the study
- You can be reached for follow-up during the study
- Your stored or collected tumor sample is usable for genetic testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares genetic testing results from a small needle biopsy to those from the surgically removed thyroid tissue. It aims to see if the biopsy alone can accurately predict the cancer's genetics, which could help guide treatment decisions.
This study tests whether a genetic test (Thyroid GuidePx) can help doctors decide the best surgical approach for thyroid nodules that may be cancerous. By identifying genetic markers before surgery, the test may help avoid unnecessary extensive surgery or ensure appropriate treatment.
This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.